Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.
US-based patient engagement technology provider Phreesia priced its shares at $18 on Wednesday and raised more than $167m in proceeds when it began trading on the New York Stock Exchange yesterday.
The offering provided exits to corporate venturing units BlueCross BlueShield Venture Partners, Ascension Ventures and Echo Health Ventures.
The company sold approximately 9.3 million shares, made up of 7.8 million newly issued stock and up to 1.5 million shares sold by certain investors owning more than 5%.
Shares briefly…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
